Australia markets open in 4 hours 48 minutes

Vistagen Therapeutics, Inc. (VTGN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.5750+0.0550 (+1.22%)
As of 03:11PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Cash flows from operating activities
Net income
-32,068
-59,248
-47,762
-17,934
Depreciation & amortisation
558.6
531.2
711.1
477.6
Stock-based compensation
2,261
3,336
3,481
2,306
Change in working capital
-400
2,028
-1,918
3,077
Accounts receivable
-
-
-
-40.6
Other working capital
-26,121
-49,927
-45,457
-12,349
Other non-cash items
-
3,559
-
-
Net cash provided by operating activities
-26,089
-49,715
-45,256
-12,073
Cash flows from investing activities
Investments in property, plant and equipment
-32.3
-212
-200.4
-275.4
Acquisitions, net
-
-528.3
0
-
Net cash used for investing activities
-560.6
-740.3
-200.4
-275.4
Cash flows from financing activities
Debt repayment
-1,300
-1,036
-3
-606.4
Common stock issued
129,548
104.4
4,439
109,475
Common stock repurchased
-
-173.9
-
-
Net cash used provided by (used for) financing activities
128,171
-1,042
10,484
114,102
Net change in cash
101,522
-51,498
-34,973
101,753
Cash at beginning of period
25,037
68,135
103,108
1,355
Cash at end of period
126,559
16,638
68,135
103,108
Free cash flow
Operating cash flow
-26,089
-49,715
-45,256
-12,073
Capital expenditure
-32.3
-212
-200.4
-275.4
Free cash flow
-26,121
-49,927
-45,457
-12,349